Bruce Linton Returns to Cannabis Sector, Takes Stake in Slang Worldwide Amid Others
Bruce Linton has returned to the cannabis sector. The co-founder and former co-CEO of Canopy Growth Corp (TSX: WEED) (NYSE: CGC) announced this morning that he would be taking an activist investor role in Slang Worldwide (CSE: SLNG) and OG DNA Genetics, while taking an active advisor role in Gage Cannabis, Better Choice Company (OTCMKTS: BTTR), and Mind Medicine Inc.
Notably, the two firms in which Linton will be taking an activist investor role in have strong connections to that of Canopy Growth. In terms of Slang Worldwide, Linton purchase 347,222 units of the firm at a price of $0.72 per unit, with each unit containing on common share and one common share purchase warrant. The firm is heavily focused on obtaining a number of well known brands in the space, and was founded by the same co-founders of Mettrum Health, a licensed producer purchased by Canopy Growth several years ago. OG DNA Genetics is another Canopy linked firm that is heavily focused on genetics and SOP’s for genetics, breeding, and cultivation.
In terms of his active advisor roles, Linton has taken on a number of titles across the space, including:
- Executive Chairman, GAGE following completion of the acquisition of Innovations – GAGE is innovating and curating the highest quality cannabis experiences possible for patients in the state of Michigan and bringing internationally renowned brands to market.
- Special Advisor, BTTR – BTTR is an animal health and wellness cannabinoid company that acquired TruPet LLC, an online seller of ultra-premium, all-natural pet food, treats and supplements, with a special focus on freeze dried and dehydrated raw products.
- Director, MMI – MMI is assembling a drug development pipeline of psychedelic inspired medicines planning or undertaking FDA trials.
The way I selected the companies was not how much equity they would give me. I turned down the most self-enriching offers. However to be transparent, all firms provided me with generous equity exposure. With each firm and space, I sought to develop a specific view of how we build enterprise value from the current activities and limit disruption. Finally, and I believe importantly, one of my participating conditions was that key insiders lock up generally for the next 12 months. Why? This is about getting back to work with alignment.
Bruce Linton
While only two of the firms are currently publicly listed companies, its unknown when the remaining will or if they will becoming issuers on either side of the border. OG DNA Genetics announced this morning however, that it is to complete a proposed business combination with Generic Gold Corp (CSE: GGC) to list on the Canadian Securities Exchange.
Linton anticipates adding a multi state operator to his list of advising firms in the near term as well as per his personal press release.
Slang Worldwide closed yesterdays session at $0.85 per share, while Better Choice Company closed at US$4.15 per share.
Information for this analysis was found via Sedar and Bruce Linton. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.
